LabKey Deploys Biologics LIMS at Valink Therapeutics for Company-Wide R&D Data Infrastructure

Implementation spans molecular registry, sample management, assay data capture, and electronic lab notebooks, with Valink building automation on LabKey’s API

 

SEATTLE, WA, UNITED STATES, September 15, 2026
Originally released by EINPresswire

LabKey, a provider of laboratory informatics software for life sciences research, today announced the deployment of LabKey Biologics LIMS at Valink Therapeutics, a biotechnology company developing antibody therapeutics. The implementation covers the Biologics LIMS molecular registry, sample management, assay data capture, electronic lab notebooks, and API: a unified R&D data infrastructure deployed across Valink’s organization.

Valink Therapeutics is developing a pipeline of complex biologics, including monoclonal antibodies, antibody-drug conjugates, bispecifics, and related formats. As the company scaled its research operations, it needed a platform that could manage sequence-level molecular registry, physical sample tracking, experimental data capture, and lab workflow management within a single, configurable environment.

Valink’s bioregistry now manages a growing library of multi-component molecule types, protein and nucleotide sequence hierarchies, variable domain structures, and target linkages, with lineage tracking connecting molecular design to physical samples throughout the research workflow. Sample and inventory management covers protein batches, barcoded aliquots, and freezer storage across multiple storage unit types. Assay infrastructure includes plate-based assay designs and instrument data processing. Electronic lab notebooks support experiment documentation, sign-off workflows, and audit compliance across the research team.

Valink’s computational team has built Python-based automation on top of LabKey’s API layer. This enables programmatic molecule uploads, inventory synchronization, and instrument data integration without vendor-managed customization.

“Valink is exactly the kind of customer LabKey Biologics is built for: a team doing serious science across complex molecule formats, with the expertise to push the platform to its full capability,” said Bernard Lee, Product Manager at LabKey. “This engagement matters because of how Valink is using it. Their automation team wired our API layer directly into their lab workflows. They built custom infrastructure on top of LabKey. That’s what turns a LIMS into durable R&D infrastructure.”

The deployment began with a defined cohort of power users and administrators. Sixteen team members are now in active onboarding, with company-wide rollout underway and all laboratory personnel targeted for full platform adoption. Valink has identified LabKey as the foundation for its longer-term R&D data strategy, including integration with downstream analytics infrastructure as the organization grows.